Novavax Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Novavax stock has a consensus rating of "Buy" and an average price target of $14.11. The average 1-year stock price forecast is 56.78% higher than the current stock price, while the lowest is $7.00 (-22.22%) and the highest is $25 (+177.78%).

Price Target: $14.11 (+56.78%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$14.11	$16.02	$25
Change	-22.22%	+56.78%	+78.00%	+177.78%

* Price targets were last updated on May 7, 2026.

Analyst Ratings

The average analyst rating for Novavax stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	5	5
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	2	2	2	2	2	2
Strong Sell	1	1	1	1	1	1
Total	9	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Geoff Meacham Citi	Citi	Sell Maintains $7	Sell	Maintains	$7	-22.22%	May 7, 2026
Steve Scala TD Cowen	TD Cowen	Hold Reiterates $8 → $9	Hold	Reiterates	$8 → $9	n/a	May 5, 2026
Sean Lee CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $16	Buy	Reiterates	$16	+77.78%	Apr 21, 2026
Mayank Mamtani B. Riley Securities	B. Riley Securities	Buy Maintains $16 → $18	Buy	Maintains	$16 → $18	+100.00%	Apr 9, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Sell Reiterates $8	Sell	Reiterates	$8	-11.11%	Apr 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

409.97M

from 1.12B

-63.51%

from 1.12B

Revenue Next Year

258.47M

from 409.97M

-36.96%

from 409.97M

EPS This Year

-0.42

from 3.27

EPS Next Year

-0.54

from -0.42

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.15B	1.98B	983.71M	682.16M	1.12B	409.97M
Revenue Growth	141.02%	72.89%	-50.37%	-30.65%	64.69%	-63.51%
Gross Profit	-1.39B	-89.48M	-94.77M	91.65M	713.62M	358.73M
Gross Margin	-121.11%	-4.51%	-9.63%	13.44%	63.52%	87.50%
Operating Income	-1.69B	-644.74M	-552.21M	-231.93M	563.24M	-72.46M
Net Income	-1.74B	-657.94M	-545.06M	-187.50M	440.30M	-79.31M
EPS	-	-	-	-	3.27	-0.42
Free Cash Flow	727.41M	-213.32M	-979.22M	-175.64M	-331.94M	-211.00M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	586.3M
Avg	410.0M
Low	262.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-47.8%
Avg	-63.5%
Low	-76.6%

EPS Forecast

EPS	2026	2027	2028
High	0.01
Avg	-0.42
Low	-0.84

EPS Growth

EPS Growth	2026	2027	2028
High	-99.8%
Avg	-
Low	-